Understanding cancer lineage plasticity: reversing therapeutic resistance in metastatic prostate cancer

被引：7
|
作者：
Ellis, Leigh [1 ,2 ]
机构：
[1] Harvard Med Sch, Dept Oncol Pathol, Dana Farber Canc Inst, Brigham & Womens Hosp, 450 Brookline Ave, Boston, MA 02215 USA
[2] Harvard Med Sch, Dept Pathol, Brigham & Womans Hosp, Boston, MA 02115 USA
来源：
PHARMACOGENOMICS | 2017年 / 18卷 / 07期
关键词：
androgen receptor; castrate-resistant prostate cancer; epigenetic therapy; EZH2; lethal prostate cancer; lineage plasticity; neuroendocrine; prostate cancer metastasis; CIRCULATING TUMOR-CELLS; N-MYC; EVOLUTION;
D O I：
10.2217/pgs-2017-0039
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：597 / 600
页数：4
相关论文
共 50 条
  • [1] Lineage plasticity-mediated therapy resistance in prostate cancer
    Blee, Alexandra M.
    Huang, Haojie
    ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (03) : 241 - 248
  • [2] RB1, Cancer Lineage Plasticity and Therapeutic Resistance
    Zhang, Letian
    Goodrich, David W.
    ANNUAL REVIEW OF CANCER BIOLOGY, 2022, 6 : 201 - 221
  • [3] A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer
    Nauseef, Jones T.
    Chu, Timothy R.
    Hooper, William F.
    Alonso, Alicia
    Oku, Ali
    Geiger, Heather
    Goldstein, Zoe R.
    Shah, Minita
    Sigouros, Michael
    Manohar, Jyothi
    Steinsnyder, Zoe
    Winterkorn, Lara
    Robinson, Brian D.
    Sboner, Andrea
    Beltran, Himisha
    Elemento, Olivier
    Hajirasouliha, Iman
    Imielinski, Marcin
    Nanus, David M.
    Tagawa, Scott T.
    Robine, Nicolas
    Mosquera, Juan Miguel
    NPJ PRECISION ONCOLOGY, 2025, 9 (01)
  • [4] Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution
    Imamura, Jarrell
    Ganguly, Shinjini
    Muskara, Andrew
    Liao, Ross S. S.
    Nguyen, Jane K. K.
    Weight, Christopher
    Wee, Christopher E. E.
    Gupta, Shilpa
    Mian, Omar Y. Y.
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [5] Novel insights into RB1 in prostate cancer lineage plasticity and drug resistance
    Ma, Min
    Zhu, Yazhi
    Xiao, Changkai
    Li, Ruidong
    Cao, Xingyu
    Kang, Ran
    Wang, Xiaolan
    Li, Ermao
    TUMORI JOURNAL, 2024, 110 (04): : 252 - 263
  • [6] Epigenetic modulations and lineage plasticity in advanced prostate cancer
    Ge, R.
    Wang, Z.
    Montironi, R.
    Jiang, Z.
    Cheng, M.
    Santoni, M.
    Huang, K.
    Massari, F.
    Lu, X.
    Cimadamore, A.
    Lopez-Beltran, A.
    Cheng, L.
    ANNALS OF ONCOLOGY, 2020, 31 (04) : 470 - 479
  • [7] Understanding and targeting prostate cancer cell heterogeneity and plasticity
    Tang, Dean G.
    SEMINARS IN CANCER BIOLOGY, 2022, 82 : 68 - 93
  • [8] Wntless expression promotes lineage plasticity and is associated with neuroendocrine prostate cancer
    D'Abronzo, Leandro S.
    Lombard, Alan P.
    Ning, Shu
    Armstong, Cameron M.
    Leslie, Amy R.
    Sharifi, Masuda
    Schaaf, Zachary A.
    Lou, Wei
    Gao, Allen C.
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2022, 10 (05): : 299 - 310
  • [9] TGFβ signaling limits lineage plasticity in prostate cancer
    Hao, Yi
    Bjerke, Glen A.
    Pietrzak, Karolina
    Melhuish, Tiffany A.
    Han, Yu
    Turner, Stephen D.
    Frierson, Henry F., Jr.
    Wotton, David
    PLOS GENETICS, 2018, 14 (05):
  • [10] Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?
    Martori, Clara
    Sanchez-Moral, Lidia
    Paul, Tony
    Pardo, Juan Carlos
    Font, Albert
    Ruiz de Porras, Vicenc
    Sarrias, Maria-Rosa
    CANCERS, 2022, 14 (02)
12345